Carlos Roca Magadan
Overview
Explore the profile of Carlos Roca Magadan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peixoto C, Joncour A, Temal-Laib T, Tirera A, Dos Santos A, Jary H, et al.
J Med Chem
. 2024 Mar;
67(7):5233-5258.
PMID: 38552030
The salt-inducible kinases (SIKs) SIK1, SIK2, and SIK3 belong to the adenosine monophosphate-activated protein kinase (AMPK) family of serine/threonine kinases. SIK inhibition represents a new therapeutic approach modulating pro-inflammatory and...
2.
Temal-Laib T, Peixoto C, Desroy N, De Lemos E, Bonnaterre F, Bienvenu N, et al.
J Med Chem
. 2023 Dec;
67(1):380-401.
PMID: 38147525
Salt-inducible kinases (SIKs) SIK1, SIK2, and SIK3 are serine/threonine kinases and form a subfamily of the protein kinase AMP-activated protein kinase (AMPK) family. Inhibition of SIKs in stimulated innate immune...
3.
de Andrade P, Mantoani S, Nunes P, Roca Magadan C, Perez C, Xavier D, et al.
Bioorg Med Chem
. 2019 Feb;
27(6):931-943.
PMID: 30765302
Acetylcholinesterase (AChE) is the key enzyme targeted in Alzheimer's disease (AD) therapy, nevertheless butyrylcholinesterase (BuChE) has been drawing attention due to its role in the disease progression. Thus, we aimed...